KLA CORP (KLAC) is a optical instruments & lenses company. Piotroski F-Score 8/8. 11 insider Form 4 filings in the last 90 days. Next earnings projected around 2026-07-30 from KLAC's year-over-year reporting pattern (not yet company-confirmed). Fundamentals from SEC filings; prices are end-of-day.
EOD daily bars · delayed, not real-time · data: DatabentoCharting by TradingView Lightweight Charts™
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
A plain-English read on KLAC plus an auto-SWOT — built from KLAC's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate KLAC using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
| Kirloskar Virendra ASVP & Chief Accounting Officer | SELL | $52K | view → |
| Higgins Bren D.EVP & Chief Financial Officer | SELL | $7.4M | view → |
| Wilkinson Mary BethEVP, CLO and Secretary | SELL | $4.1M | view → |
| WALLACE RICHARD PPresident and CEO | SELL | $10.0M | view → |
| Hanley Jeneanne MichelleDirector | SELL | $1.0M | view → |
| Kirloskar Virendra ASVP & Chief Accounting Officer | SELL | $558K | view → |
| WALLACE RICHARD PPresident and CEO | SELL | $8.1M | view → |
Projected from KLAC's own SEC 8-K filing history — the year-over-year reporting pattern (~50% land the exact day, ~90% within a week). No analyst estimates, no scraped calendars, nothing invented. It upgrades to a confirmed date + time the moment KLAC files its announcement.
KLAC has sold off after 6 of its last 8 earnings reports.
Earnings reactions have been moderate.
KLAC has traded lower after most recent earnings releases.
The average is inflated by its most volatile prints (+3.5% and -12.2%).
A more typical earnings reaction has been approximately ±3.8%.
Realized close-to-close history only — no options-implied move, no analyst estimates.
| Reported | Close-to-close |
|---|---|
| 2026-04-29 | -3.2% |
| 2026-01-29 | -12.2% |
| 2025-10-29 | +0.7% |
| 2025-07-31 | -4.1% |
| 2025-04-30 | -1.7% |
| 2025-01-30 | +3.5% |
| 2024-10-30 |
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
| -4.3% |
| 2024-07-24 | -5.6% |
| PRIMECAP Management | $3.59B | 2.8% of portfolio |
| GMO (Jeremy Grantham) | $679.1M | 1.7% of portfolio |
| Bridgewater Associates (Ray Dalio) | $160.0M | 0.7% of portfolio |
| Third Point (Dan Loeb) | $16.2M | 0.8% of portfolio |